A protocol of randomized controlled trial for Modified Xiaoyao Powder in the treatment of chronic obstructive pulmonary disease combined mild to moderate depression

INTRODUCTION: Depression is an important complication of chronic obstructive pulmonary disease (COPD), occurring in more than one-third of individuals with COPD, and its severity is closely related to the severity and acute exacerbation of COPD, significantly contributing to the risk of death from C...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Keling, Zhao, Keni, Wang, Wujun, Xiao, Wei, Xiao, Jing, Yang, Yang, Liu, Yufei, Xie, Xiaohong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
5000
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676530/
https://www.ncbi.nlm.nih.gov/pubmed/33217836
http://dx.doi.org/10.1097/MD.0000000000023220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676530/
https://www.ncbi.nlm.nih.gov/pubmed/33217836
http://dx.doi.org/10.1097/MD.0000000000023220

Ejemplares similares